Background/Aims: Ovarian cancer (OC) is the fifth leading cause of cancer-related death in women, and it is difficult to diagnose at an early stage. The purpose of this study was to explore the prognostic biological markers of OC. Methods: Univariate Cox regression analysis was used to identify genes related to OC prognosis from the Cancer Genome Atlas(TCGA) database. Immunohistochemistry was used to analyse the level of SPINK13 in OC and normal tissues. Cell proliferation, apoptosis and invasion were performed using MTT assay, flow cytometric analysis and Transwell assay, respectively. Results: We identified the Kazal-type serine protease inhibitor-13 (SPINK13) gene related to OC prognosis from the Cancer Genome Atlas (TCGA) database by univariate Cox regression analysis. Overexpression of SPINK13 was associated with higher overall survival rate in OC patients. Immunohistochemistry showed that the level of SPINK13 protein was significantly lower in OC tissues than in normal tissues (P < 0.05).In vitro experiments showed that the overexpression of SPINK13 inhibited cellular proliferation and promoted apoptosis. Moreover, SPINK13 inhibited cell migration and epithelial to mesenchymal transition (EMT). SPINK13 was found to inhibit the expression of urokinase-type plasminogen activator (uPA), while recombinant uPA protein could reverse the inhibitory effect of SPINK13 on OC metastasis. Conclusion: These results indicate that SPINK13 functions as a tumour suppressor. The role of SPINK13 in cellular proliferation, apoptosis and migration is uPA dependent, and SPINK13 may be used as a potential biomarker for diagnosis and targeted therapy in OC.
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Introduction
Ovarian cancer (OC) is the fifth leading cause of cancer-related deaths, and it only has a 30%-40% five-year survival rate worldwide [1] . In China, there were 521, 000 new patients diagnosed with OC, and approximately 225, 000 women died from this fatal disease in 2015 [2] . Ovarian tumours can be classified into epithelial (60%), germ cell (30%) and sex cordstromal tumours (8%) according to their cytological features, among which 80%-85% of malignant OCs begin in the epithelium [3] . Unfortunately, as OC is usually asymptomatic and unpredictable, most patients with OC are diagnosed at advanced stages, in whom surgery combined with platinum-and carboplatin-based chemotherapy represent the current standard therapeutic procedures [4] . Cancer is known to arise from disruptions in not only genomes but also networks of molecular interaction. Approximately 10% of OC cases are associated with the inheritance of genes such as BRCA1 and BRCA2 [5] . Advanced OC has a high relapse rate and predisposition to distant metastasis, likely due to the ability to change the phenotype of epithelial cells and convert tumour cells back to a stem cell-like state [6] . For these reasons, it is important to develop effective strategies to stratify tumours according to aggressiveness in early stages.
The SPINK13 protein has the characteristic signature of serine protease inhibitors consisting of an N-terminal signal peptide accompanied with a Kazal domain, and it belongs to the SPINK family, which has more than 10 SPINK members in humans [7, 8] . All SPINK members have been reported to be responsible for regulating serine protease activity or preventing uncontrolled proteolysis [9] . Deregulation of SPINK proteins can cause severe diseases, such as pancreatitis, skin barrier defects, celiac disease, and tumours [10] [11] [12] [13] . However, the biological role of SPINK13 in normal homeostasis and disease pathogenesis is poorly understood, and whether SPINK13 can serve as a potential diagnostic and therapeutic target of OC has not been reported.
The Cancer Genome Atlas (TCGA) is a large-scale genomic database [14] that offers open access and provides opportunities to reveal new molecular targets in several tumours, and it enables researchers to systematically understand the molecular basis of malignant tumour development and metastasis. In our previous study, we established a model to screen differentially expressed genes and identify a set of genes related to the prognosis of OC patients from the Gene Expression Omnibus (GEO) database [15, 16] . In this study, bioinformatics analysis was used to identify whether the SPINK13 gene is associated with the prognosis of OC using TCGA database. We investigated the effect of SPINK13 gene on the biological characteristics of OC in vitro to develop strategies to combat OC progression.
Materials and Methods
Database search of gene function Samples were collected from TCGA database and screened with the module described in our previous study [16] . The survival information of the patients was screened, and then the samples were divided into two groups according to the expression level of SPINK13. Kaplan-Meier (KM) survival curves were constructed using SPSS 16.0 software (Armonk, NY, USA).
Tissue samples
To detect the expression of SPINK13, fresh samples from 24 OC tissues and paired adjacent tissues (>2 cm from the cancer tissue, pathologically confirmed to have no cancerous cells) were collected from patients who underwent surgical treatment at Changhai Hospital Affiliated to Second Military Medical University (Shanghai, China) between January and December, 2010. None of the patients had received chemotherapy or radiotherapy prior to surgery. All of the patients signed informed consent for their tissues to be used for scientific research. Ethical approval for the study was obtained from the Second Military Medical University (Shanghai, China). All diagnoses were based on pathological and/or cytological evidence. The histological features of the samples were evaluated by a senior pathologist according to the classification 
Immunohistochemistry (IHC)
The tissues were fixed in 10% neutral buffered formalin and embedded in paraffin. IHC was then performed to detect the expression of SPINK13 using an IHC kit obtained from Zhuoli Biotech Co. Ltd. (Shanghai, China). Briefly, three μm-thick paraffin sections were deparaffinized, rehydrated, and heat treated with citrate buffer (pH 6.0) for 10 min for epitope retrieval. Endogenous peroxidase was blocked with 3% hydrogen peroxide for 15 min at room temperature, and non-specific binding sites were blocked with 10% normal goat serum for 30 min. The sections were incubated with anti-SPINK13 antibody (Abcam, Cambridge, UK; dilution 1:200) overnight at 4°C. Biotinylated secondary antibody was added, and the sections incubated for another 30 min at 37°C. Chromogenic reaction was developed with DAB, and the tissues were counterstained with haematoxylin at room temperature. The stained sections were scored according to the following criteria: percentage of positive cells (scored 0: <5%, 1: 5%-25%, 2: 26%-50%, 3: 51%-75%, 4: 76%-100%) plus the depth of staining (scored 0: no staining, scored 1: claybank staining, scored 2: sepia staining) to yield total scores of 0-5 (negative, +) and 6-12 (positive, +).
Reverse transcriptase-PCR (RT-PCR) and real-time PCR analysis
Total RNA was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA, USA). RNA was reverse transcribed using a miScript Reverse Transcription Kit (Qiagen, Hilden, Germany) at 42°C for 60 min and at 70°C for 5 min. Real-time PCR was conducted in quadruplicate using SYBR Green PCR Master Mix (Takara, Otsu, Japan) on an ABI StepOne Real-time PCR machine (Applied Biosystems, Foster City, CA, USA). GAPDH was used as an endogenous standard. The sequences of the primers designed by Shanghai Engineering Biotech Corp (Shanghai, China) are listed as follows: SPINK13 forward primer, 5'-CGCGGATCCATGGCTGCCTTTCCCCACAAG-3' and reverse primer, 5'-CCGCTCGAGTTAATCACATTTTCCATATTTTTCA-3'; GAPDH forward primer, 5'-AGCCACATCGCTCAGACA-3' and reverse primer, 5'-GCCCAATACGACCAAATCC-3'.
Cell culture and transfection
Human OC cell lines (SKOV3, A2780-CP, HEY, A2780 and OSCAR3), normal ovarian tissue and HEK293 cells were obtained from the Cell bank of Chinese Academy of Sciences (Shanghai, China). Cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% foetal bovine serum (all from Gibco, Grand Island, NY, USA). The cells were grown in a 37°C incubator with 5% CO 2 . SPINK13 plasmid and siRNAs were designed by Viewsolid Biotech Co. Ltd. (Beijing, China) and transfected using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol.
Western blotting
Cells were lysed in lysis buffer (Promega, Fitchburg, WI, USA) and centrifuged at 4°C, 10 000× g for 15 min. The supernatant was collected and subjected to Western blotting. The proteins were fractionated by 10% SDS-PAGE and transferred to polyvinylidene difluoride membranes (Millipore, Bedford, MA), which were then blocked with phosphate-buffered saline/Tween-20 containing 5% non-fat milk. The membranes were incubated with antibodies against E-cadherin, Vimentin and GAPDH (Cell Signalling Technology, lnc., Danvers, MA, USA). The protein-bound antibodies were detected using enhanced chemiluminescence (ECL) stable peroxide solution (PointBio, Shanghai, China). All protein bands were visualized using a FluroChem MI imaging system (Alpha Innotech, Santa Clara, CA, USA) at room temperature.
Cell proliferation and apoptosis assay
Cells were seeded in 96-well plates at a density of 5 × 10 3 cells per well. After 24 h, the cells were transfected with 50 nM of SPINK13-overexpressing vector (pcDNA-SPINK13), control vector (pcDNA3.1), siRNA-SPINK13 (si-SPINK13) or siRNA-NC (si-NC) and allowed to grow for another 48 h. Cell proliferation was measured using the MTT assay as reported previously [18] . The OD value was represented as the viability index. Three independent experiments were performed with quadruplicate samples.
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The Annexin V/propidium iodide (PI) apoptosis kit (BD Biosciences, San Jose, CA, USA) was employed to evaluate cellular apoptosis. The cells were harvested 48 h after tranfection with plasmids or siRNAs and then stained with Annexin V/PI following the manufacturer's protocol. The results were analysed using a FACScan flow cytometer (BD Biosciences, San Diego, CA, USA).
Tumour cell migration and Matrigel invasion assay
Migration and invasion of OC cells were evaluated in vitro using a modified Boyden chamber Transwell system (Corning, Tewksbury, MA, USA). Twenty-four hours after transfection according to the previous method, cells were seeded in Transwell plates for further experiments. For migration, the upper chamber was plated with 1 × 10 5 cells in 100 µL serum-free DMEM, and the lower chamber was filled with 600 µL DMEM with 20% foetal bovine serum. After 24 h of incubation at 37°C, the cells on the upper surface of the filter were removed using cotton swabs. The migrated cells that remained on the bottom surface were fixed with methanol and then stained with haematoxylin. The cells were counted under a microscope.
For Matrigel invasion assay, before OC cells were added to the upper chamber of the Transwell insert, Matrigel (12.5 µg; Sigma-Aldrich, St Louis, MO, USA) was diluted with 50 µL phosphate-buffered saline on ice and then added to the filter. The Matrigel formed a thin layer after being incubated at 37°C for 1 h. The following steps were the same as the migration assay described above.
Detection of uPA level
The supernatants of transfected with si-NC/si-SPINK13 and pcDNA3.1/pcDNA-SPINK13 were prepared. The supernatants were subjected enzyme-linked immunosorbent assay (ELISA; Xitang Biotech Co. Ltd, Shanghai, China) following the manufacturer's protocol or stored at -80°C for further analysis. Nine individual samples were studied in duplicate.
Statistical analysis
Univariate Cox regression analysis (P < 0.01) was performed to identify genes related to the prognosis of OC patients. Differences in the expression of SPINK13 between the normal and tumour tissues were determined using paired t-test. The data were analysed using Student's t-test when only two groups were present or assessed by one-way analysis of variance (ANOVA) when more than two groups were compared. Correlation analysis was performed using Pearson's analysis. The statistical analyses were performed using SPSS 16.0 software (Armonk, NY, USA), and a P-value < 0.05 was considered to be significant.
Results
Identification of OC prognosis-related genes
In total, 569 samples were collected from TCGA database screened within the module described in our previous study [16] . SPINK13 gene was found to be associated with the prognosis of OC patients by univariate Cox regression analysis. The KM survival curves (Fig. 1) showed that overexpression of SPINK13 was associated with higher overall survival rate in OC patients. We further investigated the biological role of SPINK13 in OC cells.
SPINK13 expression is repressed in human ovarian tumour tissues
Using IHC, we found that the protein level of SPINK13 was significantly lower in ovarian tumour tissues than that in 
SPINK13 suppresses proliferation and increases apoptosis of OC cells in vitro
To investigate the effect of SPINK13 on the proliferation of OC cells, pcDNA-SPINK13 or pcDNA3.1 were transiently transfected into SKOV3 cells, and si-SPINK13 or si-NC were transiently transfected into HEY cells. The results from MTT assay revealed that overexpression of SPINK13 suppressed the growth of SKOV13 cells, while knockdown of SPINK13 promoted the proliferation of HEY cells compared to the corresponding controls (Fig. 3A and 3B) .
Next, to investigate the changes in apoptosis of OC cells transfected with pcDNA-SPINK13 or si-SPINK13, cells were stained with Annexin V/PI and subjected to flow cytometric analysis. As shown in Fig. 3C , transfection of pcDNA-SPINK13 induced a substantial increase in the apoptotic rate of SKOV13 cells when compared to the rate in the corresponding control cells. Transfection of siRNA targeting SPINK13 significantly decreased apoptosis of HEY cells (Fig. 3C) . Taken together, these results demonstrated that SPINK13 served as tumour suppressor in OC.
Downregulated SPINK13 promotes metastasis and inhibits epithelial to mesenchymal transition (EMT) of OC cells
Because it is unclear whether SPINK13 affects OC metastasis, a classical Transwell system was used to investigate the effect of SPINK13 on the migration and invasion of OC cells. The results showed that the number of HEY cells migrating through the membrane and invading the Matrigel was significantly increased after transfection with si-SPINK13, indicating that 
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SPINK13 decreased the metastatic ability of OC cells (Fig. 4) . Western blotting was performed to assess the changes in expression of EMT-related molecules in the HEY cells transfected with either si-NC or si-SPINK13.
The results showed that after knockdown of SPINK13 in HEY cells, the expression of epithelial marker E-cadherin was significantly decreased, while the expression of mesenchymal marker vimentin was significantly increased (Fig.  5 ). These findings suggest that downregulation SPINK13 promotes EMT.
SPINK13
directly targets urokinase-type plasminogen activator (uPA) and affects metastasis of OC cells As SPINK13 is reported as a serine protease inhibitor and uPA is an oncogene-like serine protease, we postulated that uPA is a direct target of SPINK13. Therefore, we performed ELISA to test the expression of uPA after altering the level of SPINK13. Fig. 6A shows that transfection with si-SPINK13 increased the expression of uPA, whereas transfection with pcDNA-SPINK13 significantly decreased the expression of uPA. A Transwell system was further used to investigate whether uPA can affect the enhanced migration and invasion of ovarian cancer cells induced by the overexpression of SPINK13. The results showed that uPA could reverse the enhanced 
Discussion
The SPINK family has more than 10 members in humans, including SPINK1, SPINK2, SPINK4-9, SPINK13, and SPINK14 [7, 8] . Recent studies have found that mutant male mice with reduced SPINK2 levels exhibit impaired fertility [19] . Other Kazal protease inhibitors, including SPINK8, SPINK10, SPINK11 and SPINK12, have been identified to be highly expressed in the mouse epididymis [20] . SPINK13 is an epididymis-specific gene that functions as a protease inhibitor necessary for the regulation of critical proteases involved in early signalling events during fertilization [21] . SPINK13 also has a regulatory effect on the acrosomal reaction, and it maintains an equilibrium of protease activity for essential processes that preserve sperm and tissue integrity without affecting capacitation [8] . The SPINK13 protein has the characteristic signature of serine proteases inhibitors containing an N-terminal signal peptide accompanied with a Kazal domain [8] , but the function of its serine protease-inhibitory activity is still unclear.
OC can be classified into two types, namely, type I and type II, according to its aggressiveness [22] . Type I OC encompasses tumours that grow slowly and harbour mutations in KRAS, BRAF and CTNNB1. Type II OC is clinically aggressive and pathologically diagnosed as high grade [22] . A substantial proportion of type II OC has BRCA1/BRCA2 mutations that predispose individuals to hereditary OC and breast cancer [23, 24] . Personalized regimens for the assessment of progression and prognosis of this malignancy are required. In this study, we identified the relationship of the SPINK13 gene with OC prognosis from TCGA database by univariate Cox regression analysis. First, we demonstrated that SPINK13 expression is significantly low in OC tissues by IHC and in cell lines in vitro, and then we showed that overexpression of SPINK13 can significantly inhibit the proliferation of OC cells and increase the rate of apoptosis. These results showed that SPINK13 functions as tumour suppressor OC, which is consistent with our previous prediction.
Tumour metastasis is a complex multi-step process involving many genes [25] . EMT acts as a key event that causes tumour relapse and metastasis. EMT enables the tumour cells that do not harbour migratory or invasive abilities to acquire these abilities [26] . The activation of EMT is an important step during tumour progression. The regulatory genes or signalling pathways of EMT participate in tumour formation and metastasis, and this provides the strongest evidence to support our hypothesis [27] . Many transcription factors including zinc finger protein family members snail and slug and transcriptional repressors SIP1/ZEB-2(6) can cause transcriptional repression of epithelial makers such as E-cadherin [28, 29] . The results from this study showed that after si-SPINK13 transfection, the migratory and invasive abilities of OC cells were significantly enhanced as shown by Transwell assays. Downregulation of SPINK13 was negatively correlated with the expression of E-cadherin, but it was positively correlated with the expression of the mesenchymal marker vimentin. These findings suggest that downregulation of SPINK13 can enhance migratory and invasive abilities of cells partly by promoting EMT.
Studies have demonstrated that the uPA plasmin system represents a family of serine proteases that are involved in many physiological processes as well as in tumour pathogenesis [30] . uPAs are differentially expressed in cancer tissues compared to normal tissues, and high levels of uPA are predictive of poor clinical outcomes in OC patients [31] [32] [33] . There is abundant evidence that uPA and its cell surface receptor (uPA-R) play fundamental roles in tumour invasion and metastasis [34, 35] . Several therapeutic approaches aimed at inhibiting the functions of uPA and uPA-R have been shown to possess anti-tumour effects in vitro and in animal models [36, 37] . Our study illustrated that up-regulation of SIPNK13 can decrease Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry the expression levels of uPA and inhibit cell migration. Our experimental results also showed that uPA can completely reverse SPINK13 inhibitory function on cell migration. Therefore, there is two possibilities, one is SPINK13 inhibited the migration of OC cells by regulating uPA; the other is SPINK13 and uPA play the opposite role on migration in independent ways, and at the same time, SPINK13 could inhibit the expression of uPA in direct or indirect way. As, the regulation of SPINK13 can result in the change of uPA, in our opinion, we think uPA was, at least, involved in the SPINK13 inhibitory function on cell migration.
Conclusion
Our study showed that the SPINK13 protein level was significantly lower in OC tissues than that in normal tissues (P < 0.05). SPINK13 serves as a tumour suppressor in OC development via the inhibition of cellular proliferation and promotion of apoptosis. Downregulation of SPINK13 can significantly inhibit the migration and invasion of OC cells in which uPA was involved, and its downstream genes to activate EMT in OC cells, leading to poor prognosis. These results suggest that SPINK13 may be used as a potential target for treating OC.
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